Collective Audience Appoints Advertising Entrepreneur and Digital Healthcare Executive, Larry Krampf, to Advisor Collective
April 10, 2024 08:31 ET
|
Collective Audience, Inc.
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience-based performance advertising and media, has appointed Larry Krampf to the...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 10, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
ATA Creativity Global Announces Filing of Annual Report on Form 20-F for the Year Ended December 31, 2023
April 10, 2024 08:30 ET
|
ATA Creativity Global
BEIJING, April 10, 2024 (GLOBE NEWSWIRE) -- ATA Creativity Global ("ACG" or the "Company", Nasdaq: AACG), an international education services company focused on providing quality learning...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
April 10, 2024 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Ostin Technology Group Unveils Strategic Expansion into North American Market With its US Subsidiary Begins Operation
April 10, 2024 08:30 ET
|
Ostin Technology Group Co., Ltd.
Nanjing, China, April 10, 2024 (GLOBE NEWSWIRE) -- Ostin Technology Group Co., Ltd. ("the Company") (Nasdaq: OST), a leading supplier of display modules and polarizers based in China, announces that...
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 10, 2024 08:30 ET
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present...
Sip with Me Cups now Available at Landry’s Rainforest Café
April 10, 2024 08:30 ET
|
SRM Entertainment, Inc.
JUPITER, FL, April 10, 2024 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) is pleased to announce that SRM’s patented Sip With Me cups are now available at...
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
April 10, 2024 08:30 ET
|
Adial Pharmaceuticals, Inc
GLEN ALLEN, Va., April 10, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
April 10, 2024 08:30 ET
|
Cellebrite DI Ltd
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private...
AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024
April 10, 2024 08:30 ET
|
AFC Gamma, Inc.
WEST PALM BEACH, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it plans to report earnings for the quarter ended March 31, 2024 on...